Revenue: The sum of all revenue fields included for a company's operating activities.
Oncobiologics, Inc. (OTLK) had Revenue of $-1.21M for the most recently reported fiscal quarter, ending 2025-12-31.
| Income Statement Financials | |
|
Revenue |
$-1.21M |
$-23.06M |
|
$0.03M |
|
$-1.24M |
|
$12.28M |
|
$-13.48M |
|
$-9.57M |
|
$-23.06M |
|
$-23.06M |
|
$-23.06M |
|
$-23.06M |
|
$-23.06M |
|
$-23.06M |
|
$-13.48M |
|
$-13.45M |
|
60.20M |
|
60.20M |
|
$-0.38 |
|
$-0.38 |
|
| Balance Sheet Financials | |
$17.17M |
|
-- |
|
$1.07M |
|
$18.24M |
|
$49.06M |
|
-- |
|
$7.73M |
|
$56.79M |
|
$-38.55M |
|
$-38.55M |
|
$-38.55M |
|
64.56M |
|
| Cash Flow Statement Financials | |
$-14.94M |
|
-- |
|
$15.53M |
|
$8.08M |
|
$8.68M |
|
$0.59M |
|
$0.88M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
0.35 |
|
-- |
|
-- |
|
-- |
|
-0.95 |
|
102.45% |
|
1116.38% |
|
1116.38% |
|
-- |
|
1909.05% |
|
1909.05% |
|
$-14.94M |
|
-- |
|
-- |
|
-- |
|
-0.07 |
|
0.01 |
|
-10.54 |
|
-8.54 |
|
59.81% |
|
59.81% |
|
-126.43% |
|
59.81% |
|
$-0.60 |
|
$-0.25 |
|
$-0.25 |
|